Comparative Pharmacology
Head-to-head clinical analysis: SORBITOL 3 IN PLASTIC CONTAINER versus TRILYTE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: SORBITOL 3 IN PLASTIC CONTAINER versus TRILYTE.
SORBITOL 3% IN PLASTIC CONTAINER vs TRILYTE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Sorbitol is a sugar alcohol that acts as an osmotic diuretic. When administered intravenously, it increases plasma osmolality, drawing water from extravascular spaces into the intravascular compartment, thereby reducing intracranial pressure and cerebral edema. It is also used as a hyperosmotic laxative via oral administration, drawing water into the colon to stimulate bowel movements.
TRILYTE (polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, ascorbic acid) is an osmotic laxative. The active components induce diarrhea by osmotically drawing water into the gastrointestinal lumen, thereby increasing stool volume and stimulating peristalsis. Sodium ascorbate and ascorbic acid enhance the osmotic effect.
30 mL of 3% solution (0.9 g) administered intravenously over 30-60 minutes, typically as a single dose.
Adults: 1 liter (L) orally every 10-15 minutes until 4 L total consumed; complete ingestion within 4 hours.
None Documented
None Documented
Terminal elimination half-life is approximately 1.5-2 hours in patients with normal renal function; prolonged in renal impairment (up to 6 hours in anuria).
Not applicable; non-absorbed, acts locally in GI tract
Sorbitol is primarily excreted renally as metabolites (fructose and glucose) and unchanged drug; approximately 50-70% is recovered in urine over 24 hours, with less than 10% eliminated in feces.
Renal excretion of intact electrolyte ions; negligible drug excretion
Category C
Category C
Laxative
Laxative